General
Preferred name
Metamfetamine
Synonyms
methamphetamine ()
METHAMPHETAMINE HYDROCHLORIDE ()
Methylamfetamine hydrochloride ()
Methamphetamine hcl ()
Desoxyephedrine hydrochloride ()
Metamfetamine hydrochloride ()
Desoxyn ()
NSC-169505 ()
Methamphetamine hydrochloride cii ()
Methampex ()
J6.362B ()
(s)-phenylmethylaminopropane ()
NSC-25115 ()
(+)-Methamphetamine (hydrochloride) ()
(+)-Methamphetamine (hydrochloride) (CRM) ()
P&D ID
PD009472
CAS
826-10-8
537-46-2
139-47-9
51-57-0
Tags
natural product
drug
available
Approved by
FDA
First approval
1943
Drug Status
illicit
approved
withdrawn
Drug indication
Attention deficit hyperactivity disorder
Stimulant (central)
Pain
Max Phase
Phase 4
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
ABSORPTION Methamphetamine is rapidly absorbed from the gastrointestinal tract with peak methamphetamine concentrations occurring in 3.13 to 6.3 hours post ingestion. Moreover, when administered intranasally or as an inhalation, methamphetamine also demonstrates a high degree of absorption. It is distributed to most parts of the body. Because methamphetamine has a high lipophilicity it is distributed across the blood brain barrier and crosses the placenta.
Compound Sets
13
Cayman Chemical Bioactives
ChEMBL Approved Drugs
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
LSP-MoA library (Laboratory of Systems Pharmacology)
NPC Screening Collection
Withdrawn 2.0
ZINC Tool Compounds
External IDs
52
Properties
(calculated by RDKit )
Molecular Weight
149.12
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
1
Rotatable Bonds
3
Ring Count
1
Aromatic Ring Count
1
cLogP
1.84
TPSA
12.03
Fraction CSP3
0.4
Chiral centers
1.0
Largest ring
6.0
QED
0.69
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
ATC
N06BA03
Toxicity type
multiple
Therapeutic Class
Central Nervous System Stimulants
Source data